Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00026767 · ClinicalTrials.gov registry record
Surveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant Recipients
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 217
- Enrollment target
NCT00026767: Completed study, sponsored by National Cancer Institute (NCI).
NCT00026767 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 217 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00026767 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 217 participants
- Enrollment target
Study Summary
This study will collect data on the incidence (rate of occurrence) of fungal infections in recipients of bone marrow, stem cell or organ transplants. The data will provide information needed to develop strategies for prevention and early treatment of fungal infections in these patients. Any patient receiving bone marrow transplantation, peripheral stem cell transplantation or solid organ transplantation is eligible for this study. The survey will be conducted over a 3-year period at about 20 collaborating transplant centers. Through the annual accrual of more than 9,000 patients, it is estimated that at least 5 to 8 percent per year will have documented or suspected invasive fungal infections. The study will be conducted in three phases as follows: * Phase 1 A 6-month "start-up" phase during which sites will initiate screening and begin collecting data on incident cases of invasive fungal infections. * Phase 2 A 2-year phase in which all sites will conduct surveillance and collect data and specimens in a standardized fashion. * Phase 3 A 6-month "wrap-up" phase during which active surveillance for invasive fungal infections will be conducted only among patients who were transplanted before the beginning of this phase. Patient care will be provided through the patient s primary protocol and standard of care. ...
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2001-04-09 |
| Est. Completion | 2012-07-17 |
What the finished NCT00026767 record still lists
NCT00026767 is an observational study that tracks outcomes without assigning an intervention. The registered 217 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00026767 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00026767 about?
NCT00026767 is a clinical study titled "Surveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant Recipients". This study will collect data on the incidence (rate of occurrence) of fungal infections in recipients of bone marrow, stem cell or organ transplants. The data will provide information needed to develop strategies for prevention and early treatment of fungal infections in these patients. Any patient...
What is the current status of trial NCT00026767?
This trial is currently completed. The enrollment target is 217 participants. The study started on 2001-04-09. Estimated completion is 2012-07-17.
Who is sponsoring clinical trial NCT00026767?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05079282 · 217 participants · Phase 1
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
- NCT05470439 · 217 participants · NA
My Interprofessional Care Team for Adherence and Research Engagement Disparities
- NCT05981703 · 217 participants · Phase 1
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
- NCT06342258 · 217 participants · Phase 1
COES: Curing Order Effects on Sealants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI